Cytotoxicity of a new hemostatic agent on human pulp fibroblasts in vitro by Odabas, Mesut Enes et al.
Med Oral Patol Oral Cir Bucal. 2011 Jul 1;16 (4):e584-7.                                                                                                                                                       Cytotoxicity of a new haemostatic agent
e584
Journal section: Clinical and Experimental Dentistry
Publication Types: Research
Cytotoxicity of a new hemostatic agent on human pulp fibroblasts in vitro
Mesut E. Odabaş 1, Murat Ertük 2, Çağdaş Çınar 1, Tamer Tüzüner 3, Özlem Tulunoğlu 4 
1 PhD, University of Gazi, Faculty of Dentistry, Department of Pediatric Dentistry, Ankara, Turkey
2 Professor, University of Karadeniz Technical, Department of Microbiology and Clinical Microbiology, School of Medicine, 
Trabzon, Turkey
3 PhD, University of Karadeniz Technical, Department of Pediatric Dentistry Trabzon, Turkey
4 Professor, University of Gazi, Faculty of Dentistry, Department of Pediatric Dentistry, Ankara, Turkey
Correspondence:
University of Gazi, Faculty of Dentistry,
Department of Pediatric Dentistry,
8. Cadde 82.Sokak 06510,
Emek Ankara-Turkey
mesut@gazi.edu.tr
Received: 29/03/2010
Accepted: 26/08/2010
Abstract
Objective: The objective of this study was to evaluate  the cytotoxicity of  the plant extract ankaferd blood stopper 
(ABS) in vitro.
Study Design: ABS was eluted with fresh Dulbecco’s Modified Eagle’s Medium (DMEM) without serum for 72 
h, at 37°C. The cells treated with various dilutions of ABS were seeded into 96-well microplate at 104 /well in 
triplicates. Cells without treatment served as a control group. The number of viable cells after 48 h incubation was 
determined by a modified 3-(4, 5-dimethyl-thiazol-2-yl)-2, 5-diphenyl-tetrazolium bromide (MTT) assay. The 
relative viability of pulp cells was expressed as color intensity of the number in the experimental wells relative to 
that of the control group. Absorbances were read at 570 nm on a microplate reader with a background subtraction 
at 620 nm.
Result: The results showed that ABS was cytotoxic to human pulp fibroblasts by MTT assay.
Conclusions: The influence of cytotoxicity to human pulp fibroblasts depended on concentration of ABS. The 
more dilutions exhibited less cytotoxic characteristics compared to the more concentrated forms.
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Introduction
The goal of vital therapy is to treat reversible pulpal in-
jury and maintain pulp vitality and function. It includes 
two therapeutic approaches: indirect pulp capping in 
cases of deep dentinal cavities and direct pulp capping/
pulpotomy in cases of pulp exposures (1). Several fac-
tors influence the success of direct pulp capping/pul-
potomy. One of the factors is control of pulp bleeding, 
which is necessary to improve the favourable prognosis 
of vital pulp therapy (2). If pulp bleeding can not be con-
trolled, a blood clot on the wound surface would prevent 
intimate contact between the capping material and pulp 
tissue, thus provoking a choronic inflamatory response 
whilst impairing the healing process (2,3).
Many hemostatic agents and procedures have been used 
to control pulpal bleeding in vital therapy. The most 
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widespread technique is to control pulpal bleeding by 
applying mechanical pressure to the wound surface 
with a sterile cotton pellet. Another technique for con-
trolling pulp bleeding is the application of hemostatic 
agents (ie, ferric sulphate).
Ankaferd Blood Stopper (ABS) (Ankaferd Sağlık Ürün-
leri A.Ş., İstanbul, Turkey) which is a folkloric medici-
nal plant extract that has been introduced for bleeding 
control in clinical health sciences (4). ABS produces he-
mostatic actions by providing the encapsulated protein 
network for vital phsiological erythrocyte aggregation. 
ABS has been safetly used in patients to treat epistaxis 
(5), after tonsillectomy (6) or variceal bleeding (7). In 
addition, ABS has been used to control upper gastroin-
testinal bleeding (8), life-threatening arterial bleeding 
of the digestive tract (9), and bleeding due to solitary 
rectal ulcer (10). Moreover, the levels of coagulation 
factors II, V, VIII, IX, X, XI, and XII were not affected 
by ABS, therefore, ABS might be used in patients with 
deficient primary hemostasis (11).
The biologic and toxicologic properties of biomateri-
als are important for their clinical usage (12). In vitro 
cytotoxic screening as a primary factor of biocompat-
ibility is determined by cell culture. The most appropri-
ate cells (ie, cells homologous to the human tissues of 
ultimate concern) should be selected for in vitro toxicity 
tests (13). Moreover, pulp fibroblast are highly sensitive 
to toxic substances, indicating that pulp cells could be 
a sensitive barometer to reveal the possible adverse ef-
fects of dental materials (13,14). The aim of this study 
was to evaluate the cytotoxicity of a new hemostatic 
agent on cultured human pulp fibroblast.
Materials and Methods
Ankaferd Blood Stopper derivates from different plants 
with names of Thymus vulgaris (0.05 mg/ml), Glycyr-
rhiza glabra (0.07 mg/ml), Vitis vinifera (0.08 mg/ml), 
Alpinia officinarum (0.07 mg/ml) and Urtica dioica 
(0.06 mg/ml). 
Cell culture
The explant method was used to grow human dental 
pulp fibroblasts as described previously (15). The in-
formed consent was obtained from the patients. Briefly, 
impacted human third molars were extracted and im-
mediately after this procedure the root was removed 
by horizontal section below the cementoenamel junc-
tion with a number 330 bur at high speed with water 
spray. The pulp tissue was removed aseptically then 
was rinsed with Hank’s Balanced Salt Solution (HBSS 
without serum) (Biological Industries, Israel), and 
placed in a 10-mm glass Petri dish. Pulp tissue was cut 
into small fragments using surgical blades and tissue 
parts were picked up by a sterile needle to seed on to 
plastic surface inside a T25 tissue culture flask (Greiner 
Bio-one, Germany). Dulbecco’s Minimum Essential 
Medium (DMEM) supplemented with 20 % fetal calf 
serum (FCS) (Biochrom, Germany) and antibiotics (100 
U mL-1 penicillin, 100 µg mL-1  streptomycin, and 0.25 
µg mL-1  fungizone) was used just enough amounts to 
keep the tissue parts wet. Cultures were maintained at 
37°C in a humidified atmosphere of 5 % CO2 and 95 
% air and increasing the volume of the medium every 
other day. After enough size of monolayer cells were 
grown around the tissue parts, the cells were detached 
with 0.25 % trypsin (Sigma, USA) and 0.05 % ethyl-
enediaminetetraacetic acid (EDTA), and seeded into a 
fresh T25 flask for subculture .Cell cultures of the third 
and fourth were used in this study.
Cytotoxicity assay
ABS supplied as in 2 ml flacons was first diluted in du-
plicates in the range of 1:2-1:2028 using HBSS (without 
serum) in sterile eppendorf tubes. A total of 3×104 cells 
were placed into per dilution tube and preincubated for 
30 minutes at 37°C humidifi ed atmosphere with shak-
ing ever 10 minutes. Cells treated with various dilutions 
of the ABS were then centrifuged at 1200 rpm for 3 min 
and the cell pellet was resuspended in 0.6 ml DMEM 
supplemented with 10 % FCS and antibiotics.  The cells 
treated with various dilutions of ABS were seeded into 
96-well microplate at 104 /well in triplicates.  Cells with-
out treatment served as a control group. The number of 
viable cells after 48 h incubation at 37°C in a humidified 
atmosphere of 5 % CO2 and 95 % air was determined by 
the MTT assay as described (16). At the end of the incu-
bation period, the medium with MTT was removed, and 
100 µl dimethylsulphoxide was added to each well.  The 
plate was shaken on the microplate shaker to dissolve 
the blue MTT-formazan. The relative viability of pulp 
cells was expressed as color intensity of the number in 
the experimental wells relative to that of control. Ab-
sorbances were read at 570 nm on a microplate reader 
with background subtraction at 620 nm.
Duplicates of each concentration were performed for 
each test. All assays were repeated three times to ensure 
reproducibility.
Statistical Analysis
Statistical analysis was done by one-way analysis of 
variance (P = .05) and Tukey multiple comparasion tests 
were used for analyzing absorbance values obtained by 
the MTT assay. 
Results
The results showed that Ankaferd Blood Stopper (ABS) 
was cytotoxic to human pulp fibroblasts by MTT assay. 
The sensitivity of cytotoxicity to human pulp fibrob-
lasts depended on concentration of material tested. The 
mean±sd relative viable cell numbers were given for all 
dilution groups in table 1.
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Discussion
Many types of biomaterials have been utilized in dental 
practice procedures. Asssesing cytotoxicity based on 
several cytotoxicity testing methods is a necessary step 
in the evaluating the biocompatibility of all biomateri-
als. In vitro cytotoxity tests should be performed with 
cells homologous to the human tissue of ultimate con-
cern (15). In addition, in vitro tests are simple, reproduc-
ible, cost-effective, relevant, and suitable for evaluating 
of basic biological properties of dental materials.
The dental pulp is essentially a connective tissue com-
posed of fibroblast and odontoblast, with inherent capa-
bility to produce reperative dentin when the enviroment is 
favourable (17). The effective control of bleeding is nec-
essary to improve favourable prognosis of vital therapy 
(2). A number of agents have been used to control pulpal 
hemorrhaging for this purpose. The most known tech-
nique to control pulpal bleeding is applying mechanical 
pressure to the wound surface with a sterile cotton pel-
let. Other techniques include the applying of mechanical 
pressure with pellets soaked in saline, hydrogen perox-
ide, sodium hypochlorite (NaOCl), anesthetic solutions 
containing epinephrine, chlorhexidine or ferric sulphate 
(18-22). The application of NaOCl has been considered 
successful in adhesive pulp capping and has shown bio-
compatibility when used as a haemostatic agent (21,23). 
However, a severe cytotoxic effect has been observed 
in cell cultures with NaOCl, even in low concentrations 
(24). Ferric sulphate solution is  also known to be cyto-
toxic and to cause tissue necrosis (25). The biocompat-
ibility of chlorhexidine digluconate has not been deter-
mined completely (18). Consequently, for assessment of 
ABS cytotoxicity, human pulp fibroblasts were used to 
evaluate the cytotoxicity of ABS in this study.
The cytotoxity of ABS was evaluated with MTT assay 
in human pulp fibroblasts. Our results showed that ABS 
is cytotoxic to human pulp fibroblasts. The sensitivity 
of cytotoxicity to human pulp fibroblasts depended on 
concentration of material tested. The more dilutions ex-
hibited less cytotoxic characteristics compared to the 
more concentrated forms.
One of the most commonly used hemostatic agents in 
dentistry is ferric sulphate which also has also been re-
ported to show promising results as a dressing material 
for primary teeth pulpotomies (19). The agglutination 
of blood proteins results from the reaction of blood with 
ferric and sulphate ions. This ferric ion-protein com-
plex mechanically seals the cut vessel and producing 
hemostasis. By forming plugs that occlude the capillary 
orifices, the protein complex also prevents the forma-
tion of blood clots and thereby minimizes chances for 
inflammation and internal resorption in pulp therapy 
(3,26). The ABS mechanism involves formation of a 
protein network that acts as focal points for erythrocyte 
aggregation without affecting any individual clotting 
factor (4). Therefore, ABS may be a useful product in 
the management of pulpal bleeding during endodontic 
treatment of teeth. However, there are few clinical stud-
ies on the efficacy and safety of ABS. 
On the other hand, de Menezes et al. (27) compared  the 
cytotoxicity of pulpotomy agents. They found that ferric 
sulphate was about 332 and 32 times more toxic than min-
eral trioxide aggregate and calcium hydroxide, respec-
tively. However, Peng et al.  (28) presented a systematic 
review of the effects of formocresol and ferric sulphate 
when used as medicaments in pulpotomized primary 
molar teeth. They reported that the mean clinical and 
radiographic success rates of pulpotomy treatment with 
ferric sulphate were 91.6 % and 73.5 %, respectively.
The ideal hemostatic agents also should be free of cy-
totoxicity, but the ability of hemostasis is  more impor-
tant; however, after hemostasis is achieved, unused he-
mostatic material should be eliminated, leaving as little 
hemostatic agent as possible in order to avoid postop-
erative complications (29). 
Moreover, it should be discussed into a broader per-
spective that many materials such as peroxides for 
dental bleaching and bonding agents  used in adhesive 
dentistry all demonstrate cytotoxicity in vitro (30), yet 
they form an important part of every dentist’s restora-
tive armamentarium.
In conclusion, cytotoxicity was detected for Ankaferd 
Blood Stopper by MTT assay. However, a combination 
of two or more sensitive and quantative methods for 
safety evaluation is necessary to avoid false-negative 
results for ABS at the preclinical stage. ABS needs to 
be evaluated further because concentration used and 
exposure time to the agent are important factors affect-
ing the resulting effect. 
Table 1. Survival and growth of human pulp 
fibroblasts as measured by MTT method af-
ter exposure to various dilution of ABS for 72 
hours.
Values with the same symbol are statistically 
similar by one-way ANOVA and Tukey mul-
tiple comparison tests (P>0.05).
Dilution (%) OD570 nm  (mean±sd)
100 0.000±0.000*
 50 0.021±0.017*
        12.5 0.027±0.019*
       6.125 0.034±0.002*
       3.125 0.167±0.021*
       1.562 0.150±0.002*
0.781 0.245±0.247*
0.390   0.381±0.010**
0.195   0.388±0.011**
0.097   0.406±0.015**
0.048   0.394±0.157**
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